US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 16.650
- -0.850-4.86%
Close Nov 12 16:00 ET
- 16.800
- +0.150+0.90%
Post 19:11 ET
1.70BMarket Cap-3055P/E (TTM)
17.240High16.360Low2.64MVolume17.150Open17.500Pre Close44.04MTurnover2.62%Turnover RatioLossP/E (Static)101.85MShares34.87052wk High1.76P/B1.67BFloat Cap13.95052wk Low--Dividend TTM100.57MShs Float202.730Historical High--Div YieldTTM5.03%Amplitude9.180Historical Low16.687Avg Price1Lot Size
Intellia Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Nov 12, 2024
The average Intellia Therapeutics stock price target is 55.68 with a max estimate of 90.00 and a min estimate of 18.00
Review Intellia Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Nov 12, 2024
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
